Comparison of the Number of Image Acquisitions and Procedural Time Required for Transarterial Chemoembolization of Hepatocellular Carcinoma with and without Tumor-Feeder Detection Software

Table 4

Therapeutic efficacy of chemoembolization of hepatocellular carcinoma.

	TACE with software; (𝑛=50)	TACE without software; (𝑛=84)	𝑃
CR	34	53	0.728
PR	5	15
SD	6	8
PD	5	8
CR rate (%)	68	63	0.565
OR rate (%)	78	80	0.680

The response was evaluated according to the modified Response Evaluation Criteria in Solid Tumors [4].
CR: complete response; PR: partial response; SD: stable disease; PD: progressive disease; OR: objective response; TACE: transarterial chemoembolization.